4/A//SEC Filing
Hariri Robert J 4/A
Accession 0001641172-25-013629
CIK 0001752828other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:30 PM ET
Size
9.3 KB
Accession
0001641172-25-013629
Insider Transaction Report
Form 4/AAmended
Celularity IncCELU
Hariri Robert J
DirectorChief Executive Officer
Transactions
- Tax Payment
Class A Common Stock
2025-04-13$1.64/sh−1,154$1,893→ 2,851,454 total - Exercise/Conversion
Class A Common Stock
2025-04-13+3,281→ 2,852,608 total - Exercise/Conversion
Restricted Stock Units
2025-04-13−3,281→ 3,281 total→ Class A Common Stock (3,281 underlying)
Footnotes (4)
- [F1]Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.
- [F2]This line reflects the tax withholding on the vesting of RSUs that vested on April 13, 2025.
- [F3]Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock.
- [F4]On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4.
Documents
Issuer
Celularity Inc
CIK 0001752828
Entity typeother
Related Parties
1- filerCIK 0001398815
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 4:30 PM ET
- Size
- 9.3 KB